Search | SPORTIVO Network

priyanka added blog Health
2025-12-19 06:02:48

Global Ataxia Market Strategic Analysis and Industry Forecast
The Global Ataxia Market Size Was Valued at USD 23.12 Billion in 2023 and is Projected to Reach USD 37.43 Billion by 2032, Growing at a CAGR of 5.50% From 2024-2032. Ataxia is a neurological sign consisting of a lack of voluntary coordination of muscle movements that can include gait abnormality, speech changes, and abnormalities in eye movements. The ataxia market focuses on the development...

0 Comments 0 Shares 3K Views 0 Reviews

Please log in to like, share and comment!
Kumud added blog Health
2026-04-09 12:58:09

Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)
According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...

0 Comments 0 Shares 2K Views 0 Reviews

Please log in to like, share and comment!
Kumud added blog Health
2026-04-09 12:58:44

Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)
According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...

0 Comments 0 Shares 2K Views 0 Reviews

Please log in to like, share and comment!
rishika_2003 added blog Health
2026-03-18 05:24:18

Global Neomycin Market Set to Reach USD 620 Million by 2034 Amid Rising Infection Burden
According to a new report from Intel Market Research, the global Neomycin market was valued at USD 420 million in 2025 and is projected to reach USD 620 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2026–2034). This growth is fueled by rising antibiotic demand in human healthcare and veterinary medicine, coupled with increasing prevalence of bacterial...

0 Comments 0 Shares 4K Views 0 Reviews

Please log in to like, share and comment!
Kumud added blog Health
2026-03-23 10:30:18

Hospital-Acquired Disease Testing Market to Reach USD 724 Million by 2031 | CAGR 5.6%
According to a newly published market research report by 24LifeSciences, global hospital-acquired disease testing market was valued at USD 498 million in 2024 and is projected to reach USD 724 million by 2031, growing at a compound annual growth rate (CAGR) of 5.6% during the forecast period 2026–2034. Hospital-acquired infections (HAIs), clinically significant as nosocomial...

0 Comments 0 Shares 3K Views 0 Reviews

Please log in to like, share and comment!